201 related articles for article (PubMed ID: 7294041)
1. Aminoglycoside monitoring program.
Vakoutis J; Stein GE; Miller PB; Clayman AE
Am J Hosp Pharm; 1981 Oct; 38(10):1477-80. PubMed ID: 7294041
[TBL] [Abstract][Full Text] [Related]
2. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
[TBL] [Abstract][Full Text] [Related]
3. A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
Possidente CJ; Lynch T
Hosp Pharm; 1988 Nov; 23(11):976-8, 981-3. PubMed ID: 10290757
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal aminoglycoside dosing in critically ill patients.
Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H
Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371
[TBL] [Abstract][Full Text] [Related]
5. Program for aminoglycoside dosage calculations using an inexpensive calculator.
Gee JP; Jim LK
Am J Hosp Pharm; 1982 Sep; 39(9):1508-10. PubMed ID: 7137188
[TBL] [Abstract][Full Text] [Related]
6. Aminoglycoside dosing service provided by baccalaureate-level pharmacists.
Moore RA; Tonnies FE
Am J Hosp Pharm; 1984 Jan; 41(1):98-105. PubMed ID: 6695941
[TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside pharmacokinetic parameters in neurocritical care patients undergoing induced hypothermia.
Mercer JM; Neyens RR
Pharmacotherapy; 2010 Jul; 30(7):654-60. PubMed ID: 20575630
[TBL] [Abstract][Full Text] [Related]
8. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
Garrelts JC
Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
[TBL] [Abstract][Full Text] [Related]
9. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
[TBL] [Abstract][Full Text] [Related]
10. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.
Bookstaver PB; Johnson JW; McCoy TP; Stewart D; Williamson JC
Ann Pharmacother; 2008 Dec; 42(12):1758-65. PubMed ID: 19047358
[TBL] [Abstract][Full Text] [Related]
11. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
Hermida J; Tutor JC
Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
[TBL] [Abstract][Full Text] [Related]
12. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance.
Lim AK; Mathanasenarajah G; Larmour I
Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282
[TBL] [Abstract][Full Text] [Related]
13. Cost-benefit analysis of an aminoglycoside monitoring service.
Kimelblatt BJ; Bradbury K; Chodoff L; Aggour T; Mehl B
Am J Hosp Pharm; 1986 May; 43(5):1205-9. PubMed ID: 3087162
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients.
Townsend PL; Fink MP; Stein KL; Murphy SG
Crit Care Med; 1989 Feb; 17(2):154-7. PubMed ID: 2914447
[TBL] [Abstract][Full Text] [Related]
15. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
Dager WE; King JH
Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
[TBL] [Abstract][Full Text] [Related]
16. The aminoglycoside panel: a new approach to monitoring aminoglycoside therapy.
Gorsky JE; Latts JR
Ther Drug Monit; 1983 Jun; 5(2):169-72. PubMed ID: 6879640
[TBL] [Abstract][Full Text] [Related]
17. Outcome of patients treated by an aminoglycoside pharmacokinetic dosing service.
Sveska KJ; Roffe BD; Solomon DK; Hoffmann RP
Am J Hosp Pharm; 1985 Nov; 42(11):2472-8. PubMed ID: 4073064
[TBL] [Abstract][Full Text] [Related]
18. Gentamicin and tobramycin pharmacokinetics in patients with cystic fibrosis.
Bauer LA; Piecoro JJ; Wilson HD; Blouin RA
Clin Pharm; 1983; 2(3):262-4. PubMed ID: 6883955
[TBL] [Abstract][Full Text] [Related]
19. Drug usage evaluation of aminoglycoside-induced nephrotoxicity in a community hospital.
Wade WE; McCall CY
Hosp Formul; 1990 Oct; 25(10):1092-4, 1096. PubMed ID: 10107391
[TBL] [Abstract][Full Text] [Related]
20. Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit.
Ohler KH; Menke JA; Fuller L
Am J Perinatol; 2000; 17(6):285-90. PubMed ID: 11144309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
